TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Price, Quote, News and Overview

What is the stock price of TONIX PHARMACEUTICALS HOLDIN today?

The current stock price of TNXP is 15.71 USD. The price decreased by -0.95% in the last trading session.

What is the ticker symbol for TONIX PHARMACEUTICALS HOLDIN stock?

The exchange symbol of TONIX PHARMACEUTICALS HOLDIN is TNXP and it is listed on the Nasdaq exchange.

On which exchange is TNXP stock listed?

TNXP stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for TONIX PHARMACEUTICALS HOLDIN stock?

7 analysts have analysed TNXP and the average price target is 595 USD. This implies a price increase of 3687.4% is expected in the next year compared to the current price of 15.71. Check the TONIX PHARMACEUTICALS HOLDIN stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is TONIX PHARMACEUTICALS HOLDIN worth?

TONIX PHARMACEUTICALS HOLDIN (TNXP) has a market capitalization of 108.08M USD. This makes TNXP a Micro Cap stock.

How many employees does TONIX PHARMACEUTICALS HOLDIN have?

TONIX PHARMACEUTICALS HOLDIN (TNXP) currently has 103 employees.

What are the support and resistance levels for TONIX PHARMACEUTICALS HOLDIN (TNXP) stock?

TONIX PHARMACEUTICALS HOLDIN (TNXP) has a support level at 15.63 and a resistance level at 16.88. Check the full technical report for a detailed analysis of TNXP support and resistance levels.

Is TONIX PHARMACEUTICALS HOLDIN (TNXP) expected to grow?

The Revenue of TONIX PHARMACEUTICALS HOLDIN (TNXP) is expected to decline by -12.21% in the next year. Check the estimates tab for more information on the TNXP EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy TONIX PHARMACEUTICALS HOLDIN (TNXP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of TNXP, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of TNXP, evaluating the profitability, health, valuation and growth aspects
• TONIX PHARMACEUTICALS HOLDIN (TNXP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• TONIX PHARMACEUTICALS HOLDIN (TNXP) Sales and EPS estimates to see what analysts future expectations are.
• TONIX PHARMACEUTICALS HOLDIN (TNXP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• TONIX PHARMACEUTICALS HOLDIN (TNXP) Insider and Institutional Ownership to learn about the owners and their transactions.
• TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Chart to make your own analysis
• TONIX PHARMACEUTICALS HOLDIN (TNXP) Latest news and press-releases to stay up to date.

Does TONIX PHARMACEUTICALS HOLDIN (TNXP) stock pay dividends?

TNXP does not pay a dividend.

When does TONIX PHARMACEUTICALS HOLDIN (TNXP) report earnings?

TONIX PHARMACEUTICALS HOLDIN (TNXP) will report earnings on 2025-05-12, after the market close.

What is the Price/Earnings (PE) ratio of TONIX PHARMACEUTICALS HOLDIN (TNXP)?

TONIX PHARMACEUTICALS HOLDIN (TNXP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1966.53).

ChartMill assigns a fundamental rating of 2 / 10 to TNXP. TNXP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.

Over the last trailing twelve months TNXP reported a non-GAAP Earnings per Share(EPS) of -1966.53. The EPS decreased by -612.92% compared to the year before.

ChartMill assigns a Buy % Consensus number of 83% to TNXP. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 27.45% and a revenue growth -12.21% for TNXP